About: Elkhart General Hospital

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Elkhart General Hospital Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

hospital in Elkhart, Indiana, United States

Attributes	Values
rdf:type	Item
description	griya sakit (jv) rumah sakik (min) rumoh sakét (ace) lamin pongusapan id Amirika Sorikat (dtp) rumah sakit di Amerika Serikat (id) মার্কিন যুক্তরাষ্ট্রের একটি হাসপাতাল (bn) مستشفى في إنديانا، الولايات المتحدة (ar) hospital in Elkhart, Indiana, United States (en)
rdfs:label	Elkhart General Hospital (en)
skos:prefLabel	Elkhart General Hospital (en)
name	Elkhart General Hospital (en)
instance of	wds:Q87932226-6542D5FD-801E-4C42-A511-DB88198120C3
instance of	hospital
country	wds:Q87932226-0CAFBB2E-DFE3-4CC1-B0A2-9B9709A98D2D
country	United States of America
number of hospital beds	wds:Q87932226-012FDDEC-D383-4A1D-BC36-53B9998FA706
number of hospital beds	270 (xsd:decimal)
Ringgold ID	wds:Q87932226-36DBD2C3-0A67-4C0B-8914-178F7FFCEC33
street address	wds:Q87932226-887418E0-1DD9-421E-AFFB-623EA5ED2901
Ringgold ID	20691
street address	600 East Blvd, Elkhart, IN 46514 (en)
located in the adm...erritorial entity	wds:Q87932226-42BE9CA7-B750-4031-BCC8-783E0E2BE545
phone number	wds:Q87932226-46BFA0AB-9466-4CD3-9DD4-2A130E03E223
postal code	wds:Q87932226-046D49E4-ACD4-461D-B29F-ECCF63796988
coordinate location	wds:Q87932226-30DB1404-7B97-4D7E-8F47-60A12DFB983F
official website	wds:Q87932226-6A07F6EA-CA05-4A4A-888A-76CBCC17D96A
located in the adm...erritorial entity	Indiana
phone number	+1-574-294-2621
postal code	46514
coordinate location	POINT(-85.993207 41.679603)
official website	http://www.egh.org
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q87932226
is research site of	Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast Cancer Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Collection of Patient-Reported Symptoms and Performance Status Via the Internet Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery Trametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity Cancer Bevacizumab and Temsirolimus in Treating Patients With Recurrent or Persistent Endometrial Cancer Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer Patient-Reported Outcomes in Long-Term Survivors of Colon and Rectal Cancers Methylphenidate in Treating Patients With Fatigue Caused by Cancer Eribulin Mesylate in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy Gemcitabine and Carboplatin With or Without AZD2171 as First-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients With Primary or Recurrent Uterine, Endometrial, or Cervical Cancer Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube Cancer Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer) Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer S0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast Cancer Sorafenib in Treating Patients With Refractory Non-Small Cell Lung Cancer Pentostatin, Cyclophosphamide, and Rituximab Followed By Campath-1H in Patients With Relapsed or Refractory B-Cell CLL Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery Collecting and Storing Blood, Bone Marrow, and Other Samples From Patients With Acute Leukemia, Chronic Leukemia, or Myelodysplastic Syndromes S9925: Collecting and Storing Samples From Patients With Lung Cancer CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells Surgery to Remove the Sentinel Lymph Node and Axillary Lymph Nodes After Chemotherapy in Treating Women With Stage II, Stage IIIA, or Stage IIIB Breast Cancer Quality of Life in Female Breast Cancer Survivors and Their Spouse, Partner, or Acquaintance Gemcitabine in Treating Patients With Metastatic Cancer of Unknown Primary Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Proteomic Profiling in Diagnosing Ovarian Cancer in Patients Who Are Undergoing Surgery for an Abnormal Pelvic Mass Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia Pregabalin in Treating Women With Hot Flashes Sunitinib Malate as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer Pemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural Mesothelioma Creatine in Treating Patients With Cancer-Associated Weight Loss Soy Protein Supplement In Treating Hot Flashes in Postmenopausal Women Receiving Tamoxifen for Breast Disease Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Extensive-Stage Small Cell Lung Cancer Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma Pemetrexed Disodium and Gemcitabine in Treating Patients With Advanced Cancer of the Urothelium Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer BLP25 Liposome Vaccine and Bevacizumab After Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery Sorafenib and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer S0500 Treatment Decision Making Based on Blood Levels of Tumor Cells for Metastatic Breast Cancer Treated With Chemo Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery Pemetrexed Disodium and Carboplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer TLK286 (Telcyta) in Combination With Carboplatin (Paraplatin) Versus Doxil in Platinum Refractory or Resistant Ovarian Cancer Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast Cancer Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer Absorb IV Randomized Controlled Trial Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma Mometasone Furoate in Preventing Radiation Dermatitis in Patients Undergoing Radiation Therapy to the Breast or Chest Wall for Invasive Breast Cancer or Ductal Carcinoma in Situ Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software